Jeff S. Isenberg received his Undergraduate degree from the University of Pennsylvania graduating cum laude. He completed his medical studies at Tulane University School of Medicine graduating with a combined M.D.-M.P.H. degree. He then completed a six-year general surgery residency and obtained Board Certification in the same. He completed specialized fellowship training in reconstructive surgery at Yale University and microsurgery/hand surgery at the University of Southern California, Calif, USA. During this period, he served as an Assistant Director of plastic and reconstructive surgery at Los Angeles County Hospital. On completion of these fellowships, he obtained Board Certification in plastic and reconstructive surgery. Directly after fellowship, he was appointed Head of microsurgery, University of Oklahoma School of Medicine. After several years of academic and private practice, Dr. Isenberg was awarded a Cancer Research Fellowship by the National Cancer Institute (NCI), NIH. During his fellowship at the NIH, Dr. Isenberg, in collaboration with colleagues at the NCI, made the discovery that a ligand-receptor interaction between the matricellular protein thrombospondin-1 (TSP1) and the cell receptor CD47 is a master and redundant regulator of nitric oxide (NO) signaling. For his efforts Dr. Isenberg received the NCI Director’s Innovation Award and was twice recognized for research excellence by the NIH. Presently Dr. Isenberg is an Associate Professor of Medicine, University of Pittsburgh School of Medicine and Principal Investigator, Vascular Medicine Institute, University of Pittsburgh.
Biography Updated on 21 April 2011